On the molecular pharmacology of resveratrol on oxidative burst inhibition in professional phagocytes

. 2014 ; 2014 () : 706269. [epub] 20140128

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid24672638

Resveratrol-3,5,4'-trihydroxystilbene-possesses antioxidant activities in vitro. It dose-dependently inhibited the generation of peroxyl, hydroxyl, peroxides, and lipid peroxidation products in cell free systems. Oxidative burst of whole human blood stimulated with PMA, fMLP, OpZ, and A23187 was inhibited in a concentration-dependent way, indicating suppression of both receptor and nonreceptor activated chemiluminescence by resveratrol. Results from isolated human neutrophils revealed that resveratrol was active extracellularly as well as intracellularly in inhibiting the generation of reactive oxygen species. Liberation of ATP and analysis of apoptosis showed that in the concentration of 100 μM, resveratrol did not change the viability and integrity of isolated neutrophils. Western blot analysis documented that resveratrol in concentrations of 10 and 100 μM significantly decreased PMA-induced phosphorylation of PKC α/β II. Dose-dependent inhibition of nitrite production and iNOS protein expression in RAW 264.7 cells indicated possible interference of resveratrol with reactive nitrogen radical generation in professional phagocytes. The results suggest that resveratrol represents an effective naturally occurring substance with potent pharmacological effect on oxidative burst of human neutrophils and nitric oxide production by macrophages. It should be further investigated for its pharmacological activity against oxidative stress in ischaemia reperfusion, inflammation, and other pathological conditions, particularly neoplasia.

Zobrazit více v PubMed

Dröge W. Free radicals in the physiological control of cell function. Physiological Reviews. 2002;82(1):47–95. PubMed

Cascão R, Rosário HS, Fonseca JE. Neutrophils: warriors and commanders in immune mediated iflammatory diseases. Acta Reumatológica Portuguesa. 2009;34:313–326. PubMed

Suzuki K, Kori S, Morikawa M, Takagi A, Namiki H. Oxidative stress-mediated bimodal regulation of polymorphonuclear leukocyte spreading by polyphenolic compounds. International Immunopharmacology. 2010;10(11):1448–1455. PubMed

Filep JG, El Kebir D. Neutrophil apoptosis: a target for enhancing the resolution of inflammation. Journal of Cellular Biochemistry. 2009;108(5):1039–1046. PubMed

El Kebir D, Filep JG. Role of neutrophil apoptosis in the resolution of inflammation. TheScientificWorldJOURNAL. 2010;10:1731–1748. PubMed PMC

Natarajan SK, Becker DF. Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress. Cell Health and Cytoskeleton. 2012;4:11–27. PubMed PMC

Kori S, Namiki H, Suzuki K. Biphasic regulation of polymorphonuclear leukocyte spreading by polyphenolic compounds with pyrogallol moieties. International Immunopharmacology. 2009;9(10):1159–1167. PubMed

Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology. 2006;72(11):1439–1452. PubMed

Saiko P, Szakmary A, Jaeger W, Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutation Research. 2008;658(1-2):68–94. PubMed

Surh Y-J, Chun K-S, Cha H-H, et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutation Research. 2001;480-481:243–268. PubMed

Jančinová V, Perečko T, Nosáľ R, Košťálová D, Bauerová K, Drábiková K. Decreased activity of neutrophils in the presence of diferuloylmethane.(curcumin) involves protein kinase C inhibition. European Journal of Pharmacology. 2009;612:161–166. PubMed

Jančinová V, Nosáľ R, Lojek A, et al. Formation of reactive oxygen and nitrogen species in the presence of pinosylvin—an analogue of resveratrol. Neuroendocrinology Letters. 2010;31:79–83. PubMed

Jančinová V, Perečko T, Nosáľ R, et al. Pinosylvin decreases activity of neutrophils in vitro and in experimental arthritis. Acta Pharmacologica Sinica. 2012;10:1285–1292. PubMed PMC

Nosáľ R, Perečko T, Jančinová V, Drábiková K, Harmatha J, Sviteková K. Naturally appearing N-feruloylserotonin suppress oxidative burst of human neutrophils at protein kinase C level. Pharmacological Reports. 2011;63:790–798. PubMed

Perečko T, Jančinová V, Drábiková K, Nosáľ R, Harmatha J. Structure-efficiency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuroendocrinology Letters. 2008;29:802–805. PubMed

Perečko T, Drábiková K, Račková L, et al. Molecular targets of the natural antioxidant pterostilbene: effect on proetin kinase C, caspase-3, and apoptosis in human neutrophils in vitro. Neuroendocrinology Letters. 2010;31:101–107. PubMed

Perečko T, Drábiková K, Nosáľ R, Harmatha J, Jančinová V. Pharmacological modulation of activated neutrophils by natural polyphenols. Recent Research Developments in Pharmacology. 2011;2:27–67.

Holme AL, Pervaiz S. Resveratrol in cell fate decisions. Journal of Bioenergetics and Biomembranes. 2007;39(1):59–63. PubMed

Catalgol B, Batirel S, Taga Y, Kartal Ozer N. Resveratrol: French paradox revisited. Frontiers in Pharmacology. 2012;3:1–18. PubMed PMC

Šmidrkal J, Harmatha J, Buděšínký M, et al. Modified approach for preparing (E)-stilbens related to resveratrol, and evaluation of their potential immunobiological effects. Collection of Czechoslovak Chemical Communications. 2010;75:175–186.

Drábiková K, Jančinová V, Nosáľ R, Pečivová J, Mačičková T. Extra- and intracellular oxidant production in phorbol myristate acetate stimulated human polymorphonuclear leukocytes: modulation by histamine and H1- antagonist loratadine. Inflammation Research. 2006;55:S19–S20. PubMed

Drábikova K, Jančinová V, Nosáľ R, Pečivová J, Mačičková T, Turčáni P. Inhibitory effect of stobadine on FMLP-induced chemiluminescence in human whole blood and isolated polymorphonuclear leukocytes. Luminescence. 2007;2:67–71. PubMed

Drábiková K, Perečko T, Nosáľ R, et al. Glucomanan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacological Research. 2009;59:399–403. PubMed

Králová J, Pekarová M, Drábiková K, et al. The effects of dithiaden on nitric oxide production by RAW 264.7 cells. Interdisciplinary Toxicology. 2008;1:214–217. PubMed PMC

Ambrožová G, Pekarová M, Lojek A. Effect of polyunsaturated fatty acids on the reactive oxygen and nitrogen species production by raw 264.7 macrophages. European Journal of Nutrition. 2010;49(3):133–139. PubMed

Ou B, Hampsch-Woodill M, Prior RL. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. Journal of Agricultural and Food Chemistry. 2001;49(10):4619–4626. PubMed

Číž M, Pavelková M, Gallová L, Králová J, Kubala L, Lojek A. The influence of wine polyphenols on reactive oxygen and nitrogen species production by murine macrophages RAW 264.7. Physiological Research. 2008;57(3):393–402. PubMed

Hrbáč J, Gregor C, Machová M, et al. Nitric oxide sensor based on carbon fiber covered with nickel porphyrin layer deposited using optimized electropolymerization procedure. Bioelectrochemistry. 2007;71:46–53. PubMed

Pekarová M, Králová J, Kubala L, et al. Continuous electrochemical monitoring of nitric oxide production in murine macrophage cell line RAW 264.7. Analytical and Bioanalytical Chemistry. 2009;394:1497–1504. PubMed

Slavíková H, Lojek A, Hamar J, et al. Total antioxidant capacity of serum increased in early but not late period after intestinal ischemia in rats. Free Radical Biology & Medicine. 1998;25:9–18. PubMed

Drábiková K, Perečko T, Nosáľ R, Harmatha J, Šmidrkal J, Jančinová V. Polyphenol derivatives—potential regulators of neutrophil activity. Interdisciplinary Toxicology. 2012;5:65–70. PubMed PMC

Rotondo S, Rajtar G, Manarini S, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. British Journal of Pharmacology. 1998;123(8):1691–1699. PubMed PMC

Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, Della Ragione F. Resveratrol: from basic science to the clinic. Cell Cycle. 2007;6(20):2495–2510. PubMed

Li J, Qin Z, Liang Z. The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells. BMC Cancer. 2009;9, article 215 PubMed PMC

Miki H, Uehara N, Kimura A, et al. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. International Journal of Oncology. 2012;40(4):1020–1028. PubMed PMC

Can G, Cakir Z, Kartal M, Gunduz U, Baran Y. Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells. Anticancer Research. 2012;32:2673–2678. PubMed

de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical Society Transactions. 2007;35(5):1156–1160. PubMed

Robich MP, Chu LM, Chaudray M, et al. Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome. Surgery. 2010;148(2):453–462. PubMed PMC

Atten MJ, Attar BM, Milson T, Holian O. Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism. Biochemical Pharmacology. 2001;62(10):1423–1432. PubMed

Woo J-H, Lim JH, Kim Y-H, et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC δ signal transduction. Oncogene. 2004;23(10):1845–1853. PubMed

Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ. Inhibition of protein kinase C by resveratrol. Biochimica et Biophysica Acta. 2003;1637(1):59–69. PubMed

Kundu JK, Shin YK, Surh Y-J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochemical Pharmacology. 2006;72(11):1506–1515. PubMed

Kim MH, Yoo DS, Lee SY, et al. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects. Pharmazie. 2011;66(4):293–300. PubMed

Qureshi AA, Guan XQ, Reis JC, et al. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids in Health and Disease. 2012;11:76–93. PubMed PMC

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Pharmacological intervention with oxidative burst in human neutrophils

. 2017 Oct ; 10 (2) : 56-60.

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace